Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Decoy Therapeutics Inc.

NASDAQ: DCOY · Life Sciences · 3 alerts · CIK 1615219

Share price
$0.9010Close, Nov 16
Market cap
$2.15M
Shares outstanding
2.39MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Decoy Therapeutics Inc. filings on SEC EDGAR ↗

4:21 PM ET 10-Q
Financial Results

Decoy Therapeutics Q3 2026 Results: Net Loss of $2.99M, Loss Widens

Decoy Therapeutics Inc. reported a net loss of $7.59 million for the nine months ended September 30, 2026, compared to a $3.54 million loss in the prior year period, driven by a significant increase in research and development expenses. The company recognized $535,059 in grant revenue during the period and maintains a cash balance of approximately $8.17 million as of September 30, 2026.

Key figure
Net loss $2.99M
5:02 PM ET 8-K
Capital Raise

Decoy Therapeutics Capital Raise of $3.85M

Decoy Therapeutics entered into a warrant inducement agreement with an institutional investor for the immediate cash exercise of 1,184,434 Series B Milestone Warrants at a reduced price of $3.25 per share. The transaction generated $3.85 million in gross proceeds and included the issuance of 2,368,868 new unregistered warrants to the holder. Proceeds are intended for working capital and general corporate purposes.

Value
$3.85M
Counterparty
institutional investor

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.